Author: Dr. David Lowemann

To test the boundaries of consciousness, study animals

How can we validate tests for consciousness beyond healthy adult humans? Bayne and colleagues propose the ‘iterative natural kind strategy’ (INKS) [1]. INKS begins by taking seriously all tests with at least some face validity rather than restricting our attention to a small subset of tests that antecedently pass stringent requirements of validation. We then […]

Published on August 23, 2024

New Cancer Drugs May Also Slow Alzheimer’s Disease

A new type of cancer drug might help treat brain diseases like Alzheimer’s, mouse studies suggest. The drugs block an enzyme called indoleamine-2,3-dioxygenase 1 (IDO1), researchers reported. IDO1 inhibitors are being developed as a treatment for cancers like melanoma,… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of […]

Published on August 23, 2024

Walz’s Son Puts Attention on Learning Disabilities

An unexpected highlight of the Democratic National Convention on Night Three was an outburst of pride from the son of vice presidential candidate Tim Walz. “That’s my dad!” 17-year-old Gus Walz could be seen exclaiming Wednesday night. He stood, tears streaming down his… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., […]

Published on August 23, 2024